10 selected publications:
Holmberg D, Santoni G, von Euler-Chelpin MC, Färkkilä M, Kauppila JH, Maret-Ouda J, Ness-Jensen E, Lagergren J. Incidence and Mortality in Upper Gastrointestinal Cancer After Negative Endoscopy for Gastroesophageal Reflux Disease. Gastroenterology 2022;162:431-8.
Moore J, Kumar S, Santaolalla A, Patel P, Kapiris M, Van Hemelrijk M, Maisey N, Hill M, Lagergren J, Gossage JA, Kelly M, Baker CR, Allum WH, Cunningham D, Davies AR. Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma - a comparison of the FLOT and 'MAGIC' regimens. Eur J Cancer 2022;163:180-8.
Moore JL, Davies AR, Santaolalla A, Van Hemelrijck M, Maisey N, Lagergren J, Gossage JA, Kelly M, Baker CR; Guy’s and St. Thomas’ Esophago-gastric Research Group. Clinical relevance of the tumor location-modified Laurén classification system for gastric cancer in a Western population. Ann Surg Oncol 2022 2022 Jan 18. doi: 10.1245/s10434-021-11252-y.
Zylstra J, Whyte GP, Beckmann K, Santaolalla A, Pate J, Gervais-Andre L, Tham G, Green M, Baker C, Kelly M, Waters J, Maisey N, Lagergren J , Goh V, Gossage J, Browning M, Davies AR. Exercise prehabilitation during neo-adjuvant chemotherapy may enhance tumour regression in oesophageal cancer. Br J Sports Med 2022 doi: 10.1136/bjsports-2021-104243.
Rusu RI, Fox MR, Tucker E, Zeki S, Dunn JM, Jafari J, Warburton F, Wong T. Validation of the Lyon classification for GORD diagnosis: acid exposure time assessed by prolonged wireless pH monitoring in healthy controls and patients with erosive oesophagitis. Gut 2021;70:2230-7.
Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal reflux disease: A review. JAMA 2020;324:2536-47.
Aboul-Enein MS, Knight W, Wulaningsih W, Foley DM, Dellaportas JD, Zylstra J, Baker CR, Kelly M, Smyth E, Lagergren J, Maisey N, Allum WH, Gossage JA, Cunningham D, Davies AR. The role of surgery after prolonged primary chemotherapy for advanced oesophageal adenocarcinoma. J Surg Oncol 2021;124:1296-1305.
Bott RK, Beckmann K, Zylstra J, Wilkinson MJ, X Knight WRC, Baker CR, Kelly M, Maisey N, Waters J, Van Hemelrijck M, Smyth EC, Allum WH, Cunningham D, Lagergren J, Gossage JA, Davies AR. Adjuvant therapy following oesophagectomy for adenocarcinoma in patients with a positive resection margin. Br J Surg 2020;107:1801–10.
Smyth EC, Nyamundanda G, Cunningham D, Fontana E, Ragulan C, Tan IB, Lin SJ, Wotherspoon A, Nankivell M, Fassan M, Lampis A, Hahne JC, Davies AR, Lagergren J, Gossage JA, Maisey N, Green M, Zylstra JL, Allum WH, Langley RE, Tan P, Valeri N, Sadanandam A. A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial. Ann Oncol 2018;29:2356-62.
Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer: Seminar. Lancet 2017;390:2383-96.